Further in vivo studies related to cancer and mechanistic studies assessing the role of PPARγ agonists are required; nevertheless, this study suggests that FA could potentially be developed as an anticachetic supplement and an anticancer agent with few known side effects. This evidence concerns the gene PPARG and cancer.